Ebos shares rise 1.5 percent after $1.1 bln Symbion acquisition

Ebos shares rise 1.5 percent after $1.1 bln Symbion acquisition
By Paul McBeth May 29 (BusinessDesk) - Shares of Ebos Group rose as much as 1.5 percent when trading resumed in the company’s stock, having announced a $1.1 billion acquisition of the Symbion pharmaceutical wholesaler and distributer in Australia. The stock immediately traded at $10.05 from $9.90 when trading resumed after a $90 million placement to institutional investors at $8.50 apiece. The shares recently traded at $9.98. The stock is rated an average ‘buy’ based on two analyst recommendations compiled by Reuters, with a median target p...